Long-term Parkinson's disease progression in PIGD and TD subtypes in the PPMI cohort

被引：0
|
作者：
Aleksovski, D.
Miljkovic, D.
Antonini, A.
机构：
来源：
MOVEMENT DISORDERS | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
223
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Long-term risk of falls in an incident Parkinson’s disease cohort: the Norwegian ParkWest study
    Ylva Hivand Hiorth
    Guido Alves
    Jan Petter Larsen
    Jörn Schulz
    Ole-Bjørn Tysnes
    Kenn Freddy Pedersen
    Journal of Neurology, 2017, 264 : 364 - 372
  • [32] Long-term risk of falls in an incident Parkinson's disease cohort: the Norwegian ParkWest study
    Hiorth, Ylva Hivand
    Alves, Guido
    Larsen, Jan Petter
    Schulz, Jorn
    Tysnes, Ole-Bjorn
    Pedersen, Kenn Freddy
    JOURNAL OF NEUROLOGY, 2017, 264 (02) : 364 - 372
  • [33] Progression subtypes in Parkinson's disease identified by a data-driven multi cohort analysis
    Haehnel, Tom
    Raschka, Tamara
    Sapienza, Stefano
    Klucken, Jochen
    Glaab, Enrico
    Corvol, Jean-Christophe
    Falkenburger, Bjoern H.
    Froehlich, Holger
    NPJ PARKINSONS DISEASE, 2024, 10 (01)
  • [34] Reference LINE-1 insertion polymorphisms correlate with Parkinson’s disease progression and differential transcript expression in the PPMI cohort
    Alexander Fröhlich
    Abigail L. Pfaff
    Vivien J. Bubb
    John P. Quinn
    Sulev Koks
    Scientific Reports, 13 (1)
  • [35] Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)
    Prakash, Neha
    Caspell-Garcia, Chelsea
    Coffey, Christopher
    Siderowf, Andrew
    Tanner, Caroline M.
    Kieburtz, Karl
    Mollenhauer, Brit
    Galasko, Douglas
    Merchant, Kalpana
    Foroud, Tatiana
    Chahine, Lana M.
    Weintraub, Daniel
    Casaceli, Cindy
    Dorsey, Ray
    Wilson, Renee
    Herzog, Margaret
    Daegele, Nichole
    Arnedo, Vanessa
    Frasier, Mark
    Sherer, Todd
    Marek, Ken
    Frank, Samuel
    Jennings, Danna
    Simuni, Tanya
    Marek, Kenneth
    Siderowf, Andrew
    Seibyl, John
    Coffey, Christopher
    Tanner, Caroline
    Tosun-Turgut, Duygu
    Simunir, Tanya
    Shaw, Leslie
    Trojanowski, John
    Singleton, Andrew
    Kieburtz, Karl
    Toga, Arthur
    Mollenhauer, Brit
    Galasko, Douglas
    Poewe, Werner
    Foroud, Tatiana
    Poston, Kathleen
    Sherer, Todd
    Chowdhury, Sohini
    Frasier, Mark
    Kopil, Catherine
    Arnedo, Vanessa
    Daegele, Nichole
    Casaceli, Cynthia
    Dorsey, Ray
    Wilson, Renee
    PARKINSONISM & RELATED DISORDERS, 2019, 62 : 201 - 209
  • [36] 123-I ioflupane SPECT measures of Parkinson's disease progression in the Parkinson Progression Marker Initiative (PPMI) trial
    Seibyl, J. P.
    Jennings, D.
    Grachev, I. D.
    Coffey, C.
    Marek, K. L.
    MOVEMENT DISORDERS, 2013, 28 : S60 - S61
  • [37] Beta amyloid deposition and cognitive decline in Parkinson's disease: a study of the PPMI cohort
    Mihaescu, Alexander S.
    Valli, Mikaeel
    Uribe, Carme
    Diez-Cirarda, Maria
    Masellis, Mario
    Graff-Guerrero, Ariel
    Strafella, Antonio P.
    MOLECULAR BRAIN, 2022, 15 (01)
  • [38] Reference LINE-1 insertion polymorphisms correlate with Parkinson's disease progression and differential transcript expression in the PPMI cohort
    Frohlich, Alexander
    Pfaff, Abigail L.
    Bubb, Vivien J.
    Quinn, John P.
    Koks, Sulev
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [39] The Parkinson's progression marker initiative (PPMI) - Developing a sample size estimate for Parkinson's disease therapeutic trials
    MOVEMENT DISORDERS, 2015, 30 : S428 - S429
  • [40] Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort
    Alexander S. Mihaescu
    Mikaeel Valli
    Carme Uribe
    Maria Diez-Cirarda
    Mario Masellis
    Ariel Graff-Guerrero
    Antonio P. Strafella
    Molecular Brain, 15
12345